Headinvest, LLC Gilead Sciences, Inc. Transaction History

Headinvest, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Dec 11, 2023	BUY	$73.94 - $80.67 $40,667 - $44,368	550 New	550 $41,000
Q3 2020 Nov 24, 2020	SELL	$62.1 - $78.08 $185,865 - $233,693	-2,993 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$72.34 - $84.0 $11,936 - $13,860	165 Added 5.83%	2,993 $230,000
Q1 2020 May 12, 2020	BUY	$62.63 - $80.22 $177,117 - $226,862	2,828 New	2,828 $211,000

1,931

991M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Headinvest, LLC, based on Form 13F filings with the SEC.

Stay updated on Headinvest, LLC with notifications on news.